Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer. McCorkle JR, Gorski JW, Liu J, Riggs MB, et al. PLoS One 2021;16:e0254205.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

McCorkle JR, Gorski JW, Liu J, Riggs MB, et al. Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer. PLoS One 2021;16:e0254205.
PMID: 34347777